5J. Schulze zur Wiesch,H. Schmitz,E. Borowski,P. Borowski. The proteins of the Hepatitis C virus: Their features and interactions with intracellular protein phosphorylation[J] 2003,Archives of Virology(7):1247～1267
2Santolini E, Migliaccio G, La Monica N. Biosynthesis and Biochemical Properties of Hepatits C Virus Core Protein [J]. J Virol, 1994, 68: 3631-3641.
3Dubuhission J, Rice C M. Hepatitis C Virus Glycoprotein Folding: Disuphide Bond Formation and Association with Calnexin [J]. J Virol, 1996, 70: 778-786.
4Li Lei, Ye Lin-bai, Gao Jin-rong, Xu Jin-ping, et al. Expression and Purification of HCV Truncated Core Gene and its ELISA Essay [J]. J Wuhan Univ (Nat Sci Ed), 1999, 45(Special Issue): 17-20(Ch).
5Choo Q L, Kuo G, Ralston. Vaccination of Chimpanzees Against Infection by the Hepatitis C Virus [J]. Proc NatI Acad Sci USA, 1994, 91: 1294-1298.
6Zibert A, Schreier E, Roggendorf M. Antibodies in Human Sera Specific to Hypervariable Region 1 of Hepatitis C Virus Can Block Viral Attachment [J]. Virol, 1995, 208: 653-661.
7Ray R, Khanna A, Lagging L M, et al. Peptide Immunogen Mimicry of Putative E1 Glycoprotein-Specific Epitopes in Hepatitis C Virus [J]. J Virol, 1994, 68: 4420-4426.
8Choo Q L, Kuo G, Weiner J, et al. Isolation of a cDNA Clone Derived from a Blood-Blone Non-A,Non-B Viral Hepatitis Genome [J]. Science, 1989, 244: 359-362.
9Kuo G, Choo Q L, Alter H J, et al.Anassay for Circulating Antibodies to a Major Etiologic Virus of Human non-A, Non-B Hepatitis [J]. Science, 1989, 244: 362-364.
10Hoofnagle J H. Hepatitis C: the Clinical Spectrum of Disease [J]. Hepatology, 1997, 26 (Suppl. 1): 155-205.
1] Maylin S, Laou6nan C, Martinot - Peignoux M, et al. Role of hepatic HCV - RNA level on the severity of chronic hepatitis C and response to antiviral therapy[ J ]. J Clin Virol, 2012,53 ( 1 ) :43 - 47.
2Huang HC, Chuang CS, Hsieh YY, et al. Serum HCV RNA le'el is not associated with insulin resistance and metabolic syndrome in chron- ic hepatitis C patients with genotype 1 or 2 infection[ J]. Chang Gung Med J,2011, 34(5 ) :487 -495.
3Seiskari T,H.orsti J,Aittoniemi J. The value of HCV antigen test with reference to PCR in confirming infection in cases with indefinite anti- body test result[J]. J Clin Virol, 2011, 51(1) :90 -91.
4Vermeersch P, Van Ranst M, Lagrou K. Evaluation of the use of a combined HCV antigen/antibody assay in routine laboratory practice [J]. Acta Clin Belg, 2010, 65(4) :245 -247.
8Scanlan CN, Pantophlet R, Wormald MR, et al. The broadlyneutralizing anti-human immunodeficiency virus type 1 antibody2G12 recognizes a cluster of alpha 1—2 mannose residues on theouter face of gpl20 [J]. J Virol, 2002, 76(14): 7306-7321.
9Wang SK, Liang PH, Astronomo RD, et al. Targeting thecarbohydrates on HIV-1: Interaction of oligomannose dendronswith human monoclonal antibody 2G12 and DC-SIGN [J]. ProcNatl Acad Sci USA, 2008, 105 (10) : 3690-3695.
10Mammen M, Choi SK, Whitesides GM. Polyvalent interactions inbiological systems : implications for design and use of multivalentligands and inhibitors [ J]. Angew Chem Int Ed Engl, 1998,37(20) : 2754-2794.
